Earlier survivorship care linked to lower risk of head and neck cancer recurrence and death

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Beginning survivorship care for head and neck cancer patients earlier is linked to better survival and lower recurrence, according to the findings of a study led by researchers at the University of Pittsburgh.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

First-line subcutaneous Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) plus a PD-1 inhibitor and fixed-duration carboplatin chemotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma showeddeep and durable responses, according to the results from Cohort 5 of the phase Ib/II OrigAMI-4 study.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login